Literature DB >> 31906832

Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.

Neal S Parikh1, Hooman Kamel1, Babak B Navi1, Costantino Iadecola1, Alexander E Merkler1, Arun Jesudian2, Jesse Dawson3, Guido J Falcone4, Kevin N Sheth4, David J Roh5, Mitchell S V Elkind5,6, Daniel F Hanley7, Wendy C Ziai8, Santosh B Murthy1.   

Abstract

Background and Purpose- Cirrhosis-clinically overt, advanced liver disease-is associated with an increased risk of hemorrhagic stroke and poor stroke outcomes. We sought to investigate whether subclinical liver disease, specifically liver fibrosis, is associated with clinical and radiological outcomes in patients with primary intracerebral hemorrhage. Methods- We performed a retrospective cohort study using data from the Virtual International Stroke Trials Archive-Intracerebral Hemorrhage. We included adult patients with primary intracerebral hemorrhage presenting within 6 hours of symptom onset. We calculated 3 validated fibrosis indices-Aspartate Aminotransferase-Platelet Ratio Index, Fibrosis-4 score, and Nonalcoholic Fatty Liver Disease Fibrosis Score-and modeled them as continuous exposure variables. Primary outcomes were admission hematoma volume and hematoma expansion. Secondary outcomes were mortality, and the composite of major disability or death, at 90 days. We used linear and logistic regression models adjusted for previously established risk factors. Results- Among 432 patients with intracerebral hemorrhage, the mean Aspartate Aminotransferase-Platelet Ratio Index, Fibrosis-4, and Nonalcoholic Fatty Liver Disease Fibrosis Score values on admission reflected intermediate probabilities of fibrosis, whereas standard hepatic assays and coagulation parameters were largely normal. After adjusting for potential confounders, Aspartate Aminotransferase-Platelet Ratio Index was associated with hematoma volume (β, 0.20 [95% CI, 0.04-0.36]), hematoma expansion (odds ratio, 1.6 [95% CI, 1.1-2.3]), and mortality (odds ratio, 1.8 [95% CI, 1.1-2.7]). Fibrosis-4 was also associated with hematoma volume (β, 0.27 [95% CI, 0.07-0.47]), hematoma expansion (odds ratio, 1.9 [95% CI, 1.2-3.0]), and mortality (odds ratio, 2.0 [95% CI, 1.1-3.6]). Nonalcoholic Fatty Liver Disease Fibrosis Score was not associated with any outcome. Indices were not associated with the composite of major disability or death. Conclusions- In patients with largely normal liver chemistries, 2 liver fibrosis indices were associated with admission hematoma volume, hematoma expansion, and mortality after intracerebral hemorrhage.

Entities:  

Keywords:  aspartate aminotransferase; cerebral hemorrhage; fibrosis; hematoma; risk factors

Mesh:

Substances:

Year:  2020        PMID: 31906832      PMCID: PMC7048169          DOI: 10.1161/STROKEAHA.119.028161

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  44 in total

1.  Factors associated with significant liver fibrosis assessed using transient elastography in general population.

Authors:  Seng Chan You; Kwang Joon Kim; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Won Jae Lee; Kwang-Hyub Han
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

2.  Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.

Authors:  G Targher; L Bertolini; L Scala; G Zoppini; L Zenari; G Falezza
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

Review 3.  Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.

Authors:  Zhong-Hua Lin; Yong-Ning Xin; Quan-Jiang Dong; Qing Wang; Xiang-Jun Jiang; Shu-Hui Zhan; Ying Sun; Shi-Ying Xuan
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

4.  Predisposing factors to enlargement of spontaneous intracerebral hematoma.

Authors:  S Kazui; K Minematsu; H Yamamoto; T Sawada; T Yamaguchi
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

5.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.

Authors:  J C Hemphill; D C Bonovich; L Besmertis; G T Manley; S C Johnston
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

6.  Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.

Authors:  Sylvie Naveau; Guillaume Gaudé; Amani Asnacios; Hélène Agostini; Annie Abella; Nadège Barri-Ova; Barbara Dauvois; Sophie Prévot; Yen Ngo; Mona Munteanu; Axel Balian; Micheline Njiké-Nakseu; Gabriel Perlemuter; Thierry Poynard
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

7.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

8.  High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study.

Authors:  Llorenç Caballería; Guillem Pera; Ingrid Arteaga; Lluís Rodríguez; Alba Alumà; Rosa Ma Morillas; Napoleón de la Ossa; Alba Díaz; Carmen Expósito; Dolores Miranda; Carmen Sánchez; Rosa Ma Prats; Marta Urquizu; Angels Salgado; Magda Alemany; Alba Martinez; Irfan Majeed; Núria Fabrellas; Isabel Graupera; Ramón Planas; Isabel Ojanguren; Miquel Serra; Pere Torán; Juan Caballería; Pere Ginès
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-13       Impact factor: 11.382

9.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

10.  Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography.

Authors:  Young Dae Kim; Dongbeom Song; Ji Hoe Heo; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang Joon Kim; Kwang-Hyub Han
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

View more
  9 in total

1.  Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Tiangui Li; Peng Wang; Xiao Gong; Weelic Chong; Yang Hai; Chao You; Juan Kang; Fang Fang; Yu Zhang
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

2.  Non-invasive Liver Fibrosis Scores Are Associated With Recurrence of Postoperative Chronic Subdural Hematoma.

Authors:  Peng Zhang; Hua Wang; Han Bao; Ning Wang; Zhen Chen; Qi Tu; Xiao Lin; Yun Li; Zezheng Zheng; Yu Chen; Linhui Ruan; Qichuan Zhuge
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

3.  Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.

Authors:  Luis Ibáñez-Samaniego; Federico Bighelli; Clara Usón; Celia Caravaca; Carlos Fernández Carrillo; Miriam Romero; Mónica Barreales; Christie Perelló; Antonio Madejón; Aránzazu Caballero Marcos; Agustín Albillos; Inmaculada Fernández; Javier García-Samaniego; José Luis Calleja; Rafael Bañares
Journal:  J Infect Dis       Date:  2020-08-04       Impact factor: 5.226

4.  Association of FIB-4 index and clinical outcomes in critically ill patients with acute kidney injury: a cohort study.

Authors:  Yi-Yi Shi; Rui Zheng; Jie-Jie Cai; Zheng-Dong Fang; Wen-Jing Chen; Jing-Ye Pan; Song-Zan Qian
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

5.  Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke.

Authors:  Simon Fandler-Höfler; Rudolf E Stauber; Markus Kneihsl; Gerit Wünsch; Melanie Haidegger; Birgit Poltrum; Alexander Pichler; Hannes Deutschmann; Christian Enzinger; Peter Fickert; Thomas Gattringer
Journal:  Ther Adv Neurol Disord       Date:  2021-08-31       Impact factor: 6.570

6.  Liver Fibrosis is Associated with Clinical Outcomes in Patients with Intracerebral Hemorrhage.

Authors:  Jinjin Wang; Liheng Bian; Anxin Wang; Xiaoli Zhang; Dandan Wang; Ruixuan Jiang; Wenjuan Wang; Yi Ju; Jingjing Lu; Xingquan Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-08       Impact factor: 2.989

7.  Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients.

Authors:  Mario Romero-Cristóbal; Ana Clemente-Sánchez; Patricia Piñeiro; Jamil Cedeño; Laura Rayón; Julia Del Río; Clara Ramos; Diego-Andrés Hernández; Miguel Cova; Aranzazu Caballero; Ignacio Garutti; Pablo García-Olivares; Javier Hortal; Jose-Eugenio Guerrero; Rita García; Rafael Bañares; Diego Rincón
Journal:  Therap Adv Gastroenterol       Date:  2021-06-14       Impact factor: 4.409

8.  BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment.

Authors:  Slaven Gojkovic; Ivan Krezic; Hrvoje Vranes; Helena Zizek; Domagoj Drmic; Katarina Horvat Pavlov; Andrea Petrovic; Lovorka Batelja Vuletic; Marija Milavic; Suncana Sikiric; Irma Stilinovic; Mariam Samara; Mario Knezevic; Ivan Barisic; Ivica Sjekavica; Eva Lovric; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-06-28

9.  Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage.

Authors:  Huan Wang; Jiongxing Wu; Xue Yang; Junfeng Liu; Wendan Tao; Zilong Hao; Bo Wu; Ming Liu; Shihong Zhang; Deren Wang
Journal:  BMC Neurol       Date:  2021-12-09       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.